1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
Real-time Euronext Amsterdam  -  05/27 11:35:15 am EDT
141.90 EUR   +2.53%
05/12ROYAL DSM N.V. : Ex-dividend day for final dividend (optional)
FA
05/10Koninklijke DSM N.V. Declares Dividend for the Financial Year 2021, Payable as from 3 June 2022
CI
05/10Shareholders Vote Down Philips' Executive Compensation Plan
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Royal DSM N : DSM completes the acquisition of Vestkorn Milling

12/17/2021 | 02:49am EDT

Heerlen (NL), 17 December 2021 08:00 CEST

Royal DSM, a global purpose-led science-based company, today announces the completion of its acquisition of Vestkorn Milling for an enterprise value of €65m. This acquisition of one of Europe's leading producers of pea- and bean-derived ingredients for plant-based protein products was first announced on 29 November 2021.

Vestkorn Milling supplies the buoyant alternative protein market with proteins, starches and dietary fibers for plant-based foods, pet food and animal feed. These are highly complementary to DSM's broad offering to plant-based food and beverage companies, which includes vitamins, algal lipids and minerals that improve nutritional value; texturizing hydrocolloids; and flavors and yeast extracts as well as enzymes that improve protein taste and functionality.

The acquisition is a further step in DSM's strategy to build an alternative protein business and will provide synergy with DSM's innovative CanolaPRO™ rapeseed protein isolate, which will commercially launch next year.

DSM
Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large. DSM and its associated companies employ approximately 23,000 people around the world and deliver annual net sales of about €10 billion. The company was founded in 1902 and is listed on Euronext Amsterdam.

Disclaimer

Koninklijke DSM NV published this content on 17 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 December 2021 07:48:03 UTC.


© Publicnow 2021
All news about ROYAL DSM N.V.
05/12ROYAL DSM N.V. : Ex-dividend day for final dividend (optional)
FA
05/10Koninklijke DSM N.V. Declares Dividend for the Financial Year 2021, Payable as from 3 J..
CI
05/10Shareholders Vote Down Philips' Executive Compensation Plan
MT
05/10ROYAL DSM N.V. : Dividends
CO
05/08ROYAL DSM N.V. : Proxy Statments
CO
05/06ROYAL DSM N.V. : Share buyback
CO
05/06Public Joint Stock Company KuibyshevAzot acquired Volgaplast Compounding Ltd from Konin..
CI
05/06Public Joint Stock Company KuibyshevAzot acquired remaining 51% stake in Volgalon Ltd O..
CI
05/03GLOBAL MARKETS LIVE : BP, Pfizer, Expedia, Citigroup, Amazon...
05/03DSM earnings beat expectations as strong demand offsets inflation
RE
More news
Analyst Recommendations on ROYAL DSM N.V.
More recommendations
Financials
Sales 2022 10 077 M 10 796 M 10 796 M
Net income 2022 909 M 974 M 974 M
Net Debt 2022 897 M 961 M 961 M
P/E ratio 2022 27,2x
Yield 2022 1,85%
Capitalization 24 356 M 26 093 M 26 093 M
EV / Sales 2022 2,51x
EV / Sales 2023 2,37x
Nbr of Employees 21 358
Free-Float 94,5%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 141,90 €
Average target price 183,72 €
Spread / Average Target 29,5%
EPS Revisions
Managers and Directors
Dimitri de Vreeze Member-Management Board
Géraldine Matchett Member-Management Board
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ROYAL DSM N.V.-28.33%26 093
NESTLÉ S.A.-10.36%328 063
MONDELEZ INTERNATIONAL, INC.-3.85%86 495
ARCHER-DANIELS-MIDLAND COMPANY31.57%49 693
THE KRAFT HEINZ COMPANY5.38%45 372
THE HERSHEY COMPANY9.89%43 082